United States multicenter clinical usage study of the STAN 21 electronic fetal monitoring system.

Journal article

OBJECTIVE: The fetal electrocardiogram system for electronic fetal monitoring (EFM) (STAN S21, Neoventa Medical, Moelndal, Sweden) has led to improved perinatal outcomes in other countries. We aimed to assess the ability of United States (US) obstetricians to use this system appropriately for intrapartum care. STUDY DESIGN: A prospective nonrandomized trial was conducted in 6 sites. Enrollment required a singleton vertex fetus, >36 weeks' gestation, with indications for direct fetal monit...

Expand abstract

Authors: Devoe, L; Ross, M; Wilde, C; Beal, M; Lysikewicz, A

• Journal: American journal of obstetrics and gynecology
• Volume: 195
• Issue: 3
• Pages: 729-734
• Publication date: 2006-09-01
• DOI: 10.1016/j.ajog.2006.06.002
• EISSN: 1097-6868
• ISSN: 0002-9378
• Language: English
• Keywords: Acidosis; Humans; Predictive Value of Tests; Fetal Monitoring; Heart Rate, Fetal; Fetal Diseases; Electrocardiography; Prospective Studies; Feasibility Studies; United States